Century Therapeutics, Inc Company Contacts

Century Therapeutics, Inc

https://www.centurytx.com/
Our genetically engineered, iPSC-derived cell products are designed to specifically target hematologic and solid tumor cancers, with a broadening application to autoimmune diseases. We are leveraging our expertise in cellular reprogramming, genetic engineering, and manufacturing to develop therapies with the... Read More
Contacts

Country

United States

City

Philadelphia

Headquarters

Philadelphia, Pennsylvania

Profile

Founded

2018

Industry

Biotechnology

Size

201 - 500

Funding

Total Rounds

4

Last Round

Wed Apr 10 2024

Last Round Series

Post IPO equity

Last Round Raised

$ 60,000,000